Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2605-68-7

Post Buying Request

2605-68-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2605-68-7 Usage

General Description

1-Methoxycarbonyl-ethylidenetriphenylphosphorane (sometimes simply referred to as methoxycarbonyl phosphorane) is a chemical compound with the molecular formula C24H20O2P. 1-METHOXYCARBONYLETHYLIDENETRIPHENYLPHOSPHORANE is part of the phosphorane family, which are pentavalent phosphorus compounds. Its most recognizable feature is the phosphorous atom surrounded by four different groups in a tetrahedral arrangement and a formal charge of +1. The "1-methoxycarbonyl" refers to the ethylidene group (-CH2-) attached to a methoxy carbonyl (-COOCH3) group. This combination of features makes it a potentially interesting compound for further exploration in various chemical reactions, but currently, there is limited public information regarding its specific applications.

Check Digit Verification of cas no

The CAS Registry Mumber 2605-68-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,0 and 5 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2605-68:
(6*2)+(5*6)+(4*0)+(3*5)+(2*6)+(1*8)=77
77 % 10 = 7
So 2605-68-7 is a valid CAS Registry Number.

2605-68-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(triphenyl-λ<sup>5</sup>-phosphanylidene)propanoate

1.2 Other means of identification

Product number -
Other names 1-carbomethoxyethylidene triphenylphosphine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2605-68-7 SDS

2605-68-7Relevant articles and documents

SYNTHESIS AND DETERMINATION OF THE ABSOLUTE CONFIGURATION OF THE MACROLIDE (+)-CONGLOBATIN

Schregenberger, Christian,Seebach, Dieter

, p. 5881 - 5884 (1984)

(+)-Conglobatin is synthesized from (-)-(2S,4R)-2,4-dimethyl glutaric acid halfester in 15 steps (total yield 4.4percent).The synthesis proves the sense of chirality of the natural (-)-conglobatin to be opposite to the one previously assigned.

7-Step total synthesis of (+)-EBC-329: Photoisomerisation reveals new: Seco -casbane family member

Vanden Berg, Timothy J.,Pinkerton, David M.,Williams, Craig M.

, p. 7102 - 7105 (2017)

The first seco-casbane, EBC-329, isolated from the Australian rainforest, was synthesised from (+)-2-carene in seven steps. This endeavour not only established the absolute stereochemical assignment as (8R,9S)-EBC-329, but also identified, via photoisomer

Ring-closing metathesis approaches towards the total synthesis of rhizoxins

Altmann, Karl-Heinz,Liniger, Marc,Neuhaus, Christian M.

supporting information, (2020/10/18)

Efforts are described towards the total synthesis of the bacterial macrolide rhizoxin F, which is a potent tubulin assembly and cancer cell growth inhibitor. A significant amount of work was expanded on the construction of the rhizoxin core macrocycle by ring-closing olefin metathesis (RCM) between C(9) and C(10), either directly or by using relay substrates, but in no case was ringclosure achieved. Macrocycle formation was possible by ring-closing alkyne metathesis (RCAM) at the C(9)/C(10) site. The requisite diyne was obtained from advanced intermediates that had been prepared as part of the synthesis of the RCM substrates. While the direct conversion of the triple bond formed in the ring-closing step into the C(9)-C(10) E double bond of the rhizoxin macrocycle proved to be elusive, the corresponding Z isomer was accessible with high selectivity by reductive decomplexation of the biscobalt hexacarbonyl complex of the triple bond with ethylpiperidinium hypophosphite. Radical-induced double bond isomerization, full elaboration of the C(15) side chain, and directed epoxidation of the C(11)-C(12) double bond completed the total synthesis of rhizoxin F.

NOVEL LACTAM DERIVATIVES HAVING THERAPEUTIC EFFECT ON CANCERS

-

Paragraph 0033-0034; 0053-0055, (2016/11/14)

The present invention relates to a novel lactam derivative having a cancer therapeutic effect or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing the same as an active ingredient. The novel lactam derivative in accordance with the present invention is capable of selectively and effectively inhibiting the growth of cancer cells, that is B-cell non-Hodgkinandprime;s lymphoma, thereby being usefully used as a pharmaceutical composition for treating cancer or inhibiting the growth of cancer cells.COPYRIGHT KIPO 2015

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2605-68-7